Enteral nutrition    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
96Crohn disease19

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
19 / 2,209 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04530877
(ClinicalTrials.gov)
December 1, 202024/8/2020Exclusive Enteral Nutrition vs. Infliximab in Chinese CD PatientsComparative Effectiveness of Exclusive Enteral Nutrition and Infliximab in Chinese Children With Active Crohn's DiseaseCrohn's Disease;Exclusive Enteral Nutrition;Infliximab;Mucosal HealingBiological: Infliximab;Dietary Supplement: Exclusive Enteral NutritionChildren's Hospital of Fudan UniversityNULLNot yet recruiting1 Year18 YearsAll80Phase 4NULL
2NCT04398836
(ClinicalTrials.gov)
September 202018/7/2019Preoperative Nutrition for Crohn's Disease PatientsPreoperative Nutrition for Crohn's Disease PatientsMalnutrition;Crohn DiseaseDietary Supplement: Exclusive Enteral Nutrition;Other: High energy / protein diet.;Other: Standard nutritionTel-Aviv Sourasky Medical CenterNULLNot yet recruiting18 Years70 YearsAll144Phase 3Israel
3NCT04225689
(ClinicalTrials.gov)
January 10, 202020/12/2019The Intensive Post Exclusive Enteral Nutrition StudyThe Intensive Post Exclusive Enteral Nutrition Study (iPENS): A Randomised Trial to Evaluate CD-TREAT Diet as a Food Reintroduction Regime in Children and Young Adults With Crohn's DiseaseCrohn DiseaseOther: CD-TREAT dietNHS Greater Glasgow and ClydeUniversity of GlasgowRecruiting6 Years17 YearsAll58N/AUnited Kingdom
4NCT03833596
(ClinicalTrials.gov)
October 25, 201821/12/2018Exclusive Enteral Nutrition and Corticosteroids Therapy in Crohn's Disease (EENCD)Synergistic Effect of Exclusive Enteral Nutrition Formula in Addition to Corticosteroids Therapy to Induce Clinical Remission in Patients With Crohn's Disease: a Pilot Study Involving a Multidimensional Assessment of Potential MechanismsCrohn's DiseaseDrug: Prednisone;Dietary Supplement: Exclusive Enteral NutritionMcMaster UniversityNestléTerminated18 Years75 YearsAll3Phase 4Canada
5NCT04160325
(ClinicalTrials.gov)
May 14, 20183/11/2019Effect of the Exclusive Enteral Nutrition Combined With Azathioprine for Remission of Crohn's Diseases After SurgeryThe Effect of the Exclusive Enteral Nutrition Combined With Azathioprine in Maintaining Remission of Patients With Crohn's Diseases After SurgeryCrohn DiseaseDietary Supplement: postoperative 3-month exclusive enteral nutrition;Drug: azathioprine;Other: normal dietZhu WeimingSixth Affiliated Hospital, Sun Yat-sen University;Sir Run Run Shaw Hospital;The First Affiliated Hospital of Anhui Medical University;Beijing Tsinghua Changgung HospitalRecruiting18 Years65 YearsAll198N/AChina
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
6NCT03755583
(ClinicalTrials.gov)
February 1, 201718/11/2018Effect of Exclusive Enteral Nutrition on Disease Process, Nutritional Status and Gastrointestinal Microbiota for Chinese Children With Crohn's DiseaseEffect of Exclusive Enteral Nutrition on Disease Process, Nutritional Status and Intestinal Microbiota for Chinese Children With Crohn's DiseaseCrohn Disease;Enteral Nutrition;Gastrointestinal MicrobiomeDietary Supplement: Exclusive Enteral NutritionChildren's Hospital of Fudan UniversityNULLCompleted1 Year17 YearsAll31N/AChina
7NCT02231814
(ClinicalTrials.gov)
December 201627/8/2014Pilot Study of Partial Enteral Nutrition With a Unique Diet for the Treatment of Adult Patients With Crohn's DiseaseDietary Therapy Using Partial Enteral Nutrition and the Crohn's Disease Exclusion Diet (CDED) for Induction and Maintenance of Remission in Mild to Moderate Crohn's Disease in Adults- A Pilot StudyCrohn's DiseaseDietary Supplement: Crohns Disease Exclusion Diet + PEN;Other: Crohns Disease Exclusion DietProf. Arie LevineNULLRecruiting18 Years55 YearsAll40N/AIsrael
8NCT02998827
(ClinicalTrials.gov)
November 201624/11/2016Thalidomide Results in Diminished Ovarian Reserve in Reproductive Age Female IBD PatientsCrohn DiseaseDrug: Thalidomide;Drug: infliximab, azathioprine;Other: enteral nutritionSixth Affiliated Hospital, Sun Yat-sen UniversityNULLEnrolling by invitationN/AN/AFemale90N/ANULL
9NCT02897661
(ClinicalTrials.gov)
August 201614/8/2016Washed Microbiota Transplantation Improves Nutritional Status of Patients With Crohn's DiseaseWashed Microbiota Transplantation Combining Exclusive Enteral Nutrition Contribute to Nutritional Improvement of Patients With Crohns' DiseaseCrohn's DiseasesProcedure: WMT;Dietary Supplement: EENThe Second Hospital of Nanjing Medical UniversityNULLRecruiting18 Years65 YearsAll30N/AChina
10NCT02517684
(ClinicalTrials.gov)
April 20151/7/2015Top-down Infliximab Study in Kids With Crohn's DiseaseTop-down Infliximab Study in Kids With Crohn's DiseaseCrohn's DiseaseDrug: Infliximab;Drug: Prednisolone;Other: Exclusive enteral nutrition;Drug: AzathioprineErasmus Medical CenterZonMw: The Netherlands Organisation for Health Research and Development;Hospira, now a wholly owned subsidiary of PfizerActive, not recruiting3 Years17 YearsAll100Phase 4Belgium;Finland;Netherlands;Denmark;Italy;Poland
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
11NCT02201693
(ClinicalTrials.gov)
December 12, 201417/7/2014Cyclic Exclusive Enteral Nutrition as Maintenance Therapy for Pediatric Crohn's DiseaseRandomised Trial Comparing 12 Months of Cyclic Enteral Nutrition to Supplementary Enteral Nutrition as Maintenance Therapy for Pediatric Crohn's DiseaseCrohn's DiseaseDietary Supplement: MODULEN IBDAssistance Publique - Hôpitaux de ParisGETAID PediatricActive, not recruiting6 Years18 YearsAll100N/AFrance
12NCT02426567
(ClinicalTrials.gov)
November 201417/4/2015The Impact of Crohn's Disease-TReatment-with-EATing Diet and Exclusive Enteral Nutrition on Healthy Gut BacteriaAn Exploratory Study on the Impact of a Food-based Restrictive Diet (Crohn's Disease-TReatment-with EATing/CD-TREAT Diet) and Liquid Exclusive Enteral Nutrition (EEN) on Healthy Gut Microbiota Composition and Metabolic ActivityCrohn's Disease;Dietary ModificationOther: Exclusive Enteral Nutrition (EEN);Other: Crohn's Disease TReatment-with-EATing diet (CD-TREAT diet)University of GlasgowNULLCompleted18 YearsN/ABoth28N/AUnited Kingdom
13NCT02056418
(ClinicalTrials.gov)
January 201424/1/2014Effects of Enteral Nutrition and Corticosteroid on Intestinal Flora in Induction Remission of Crohn Disease in AdultA Randomized, Controlled, Single-blind Study of Effects of Enteral Nutrition and Corticosteroid on Intestinal Flora in Induction Remission of Crohn Disease in AdultCrohn DiseaseDietary Supplement: enteral nutrition;Drug: corticosteroidJinling Hospital, ChinaNULLActive, not recruiting18 Years75 YearsBoth30Phase 4China
14NCT02887287
(ClinicalTrials.gov)
July 201329/8/2016Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's DiseaseEfficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease With Complications or Failure of Medical TreatmentDrug: EENSun Yat-sen UniversityNULLCompleted18 Years60 YearsBoth48N/AChina
15NCT02233062
(ClinicalTrials.gov)
May 20131/9/2014Impact of Exclusive Enteral Nutrition Therapy on Sperm Quality of Patients With Crohn's DiseaseImpact of Exclusive Enteral Nutrition Therapy on Sperm Quality of Male Patients With Crohn's DiseaseCrohn's DiseaseDietary Supplement: Exclusive Enteral Nutrition TherapyJinling Hospital, ChinaNULLCompleted18 Years40 YearsMale12N/AChina
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
16NCT01820247
(ClinicalTrials.gov)
December 201225/3/2013Efficacy Study of Tripterygium Glycoside Combined With Enteral Nutrition in the Treatment of Crohn's Disease for Induction RemissionEfficacy Study of Tripterygium Glycoside Combined With Enteral Nutrition in the Treatment of Crohn's Disease for Induction RemissionCrohn's DiseaseDrug: enteral nutrition;Drug: Tripterygium glycosidesZhu WeimingNULLRecruiting18 Years75 YearsBoth100N/AChina
17NCT01823029
(ClinicalTrials.gov)
November 201225/3/2013Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency AnemiaCrohn's DiseaseDrug: erythropoietin;Drug: enteral nutrition.;Drug: injection of ironJinling Hospital, ChinaMinistry of Health, ChinaCompleted18 Years75 YearsBoth387N/AChina
18NCT01823042
(ClinicalTrials.gov)
October 201225/3/2013The Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD)A Randomized, Controlled, Open-label Study to Assess the the Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD).Crohn's DiseaseDrug: azathioprine+enteral nutrition;Drug: AzathioprineJinling Hospital, ChinaNULLRecruiting18 Years75 YearsBoth100N/AChina
19NCT00265772
(ClinicalTrials.gov)
November 200514/12/2005Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular BasisPhase IV Study Comparing a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular BasisCrohn's Disease;PediatricDrug: MODULEN IBD (R) (specific Enteral Nutrition);Drug: prednisolonHôpital Necker-Enfants MaladesInstitut National de la Santé Et de la Recherche Médicale, France;NestléRecruiting6 Years18 YearsBoth24Phase 4France